Anatoly Victorovich Semenenko

Anatoly Victorovich Semenenko

Auto-generated profile, based on publicly available information

Anatoly Victorovich Semenenko

National Research Center of Epidemiology and Microbiology named after Honorary Academician N. F. Gamaleya of the Ministry of Health of the Russian Federation, Moscow, Russia

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2023 in Лечащий врач
Verified
Journal Article
Closed access
EKE.O. Kochetova
E.O. Kochetova
OSO.V. Shamsheva
O.V. Shamsheva
IPI.V. Polesko
I.V. Polesko
ASA.V. Semenenko
A.V. Semenenko
OMO.A. Maiorova
O.A. Maiorova
VGV.V. Gorev
V.V. Gorev
According to the World Health Organization, there are about 300 million people worldwide living with chronic hepatitis B, with about 1.5 million new infections occurring each year. In the Russian Federation, starting from the new century, there has been a gradual decrease in the incidence of acute hepatitis B, which retains the status of a socially significant viral infection. Vaccination against hepatitis B was included in the National Immunization Schedule in December 1997. by order of the Ministry of Health of the Russian Federation No. 375, which was later (in September 1998) enshrined in the Federal Law "On Immunoprophylaxis of Infectious Diseases". Currently, the main indicator of the body's protection against infection with the hepatitis B virus after immunoprophylaxis is the level of post-vaccination antibodies of the IgG class to HBsAg (anti-HBs), which can be determined using serological tests. The results of a study of the intensity of post-vaccination immunity against hepatitis B in children and young people vaccinated in the first year of life with a monocomponent recombinant hepatitis B vaccine are presented. A high proportion of children (85.5%) with anti-hepatitis B indicators at low (10-100 mMU/ml) or practically undetectable (below 10 mMU/ml) has been established.ml) levels. The results obtained correlate with a high proportion of children with a burdened premorbid background (87.1%) and, probably, the presence of immunodeficiency conditions. In young people, the proportion of seronegativation was 43.2%, and in combination with persons with low-level antibodies - 82.8% of the total number of examined. Thus, due to the weak response to the recombinant hepatitis B vaccine and the high medical and social significance of hepatitis B infection, various approaches are currently being developed to enhance the effectiveness of vaccination: changes in the vaccination regimen; correction of immune system functions to restore an adequate response to vaccine preparations, the use of various adjuvants, including recombinant interferons.

29 April 2023 in Sanitarnyj vrač (Sanitary Doctor)
Verified
Journal Article
Closed access
EZE. V. Zhukova
E. V. Zhukova
MMM. A. Mirskaya
M. A. Mirskaya
ASA. V. Semenenko
A. V. Semenenko
TGT. P. Gotvyanskaya
T. P. Gotvyanskaya
GNG. Yu. Nikitina
G. Yu. Nikitina
The organization of an effective infection control system is one of the main tasks of medical organizations to prevent the occurrence and spread of infections associated with the provision of medical care (ISMP). In connection with the pandemic of the new coronavirus infection (COVID-19) that has engulfed all countries of the world, the problem of ISMP and infection control (IC) in medical organizations has become particularly relevant. The aim of the study was to assess the adherence of medical workers to the principles of IC in the departments for patients with COVID-19 and to determine the occupational risk factors of infection of personnel during the pre-vaccination period of the pandemic. The study included medical workers of «covid» hospital departments (n = 216; age 25–54 years), of which 105 doctors (41.7 %), average medical workers (nurses and nurses) — 111 people (58.3 %). All employees were trained in biological safety and conducting sanitary and anti-epidemic measures with COVID-19 before starting work in the hospital. In most of the staff (114 people, 52.8 ± 8.7 %), the compliance of the IC was assessed as high in the absence of detection of violations of the requirements of infectious safety. The average degree of adherence to IR measures was found in 102 observed medical workers (47.2 ± 9.9 %). In the cohort of medical workers with a high degree of adherence to IR measures, 2 people suffered a new coronavirus infection, which is 1.8 ± 0.5 %, while among the staff with a moderate degree of adherence (n = 102) 10 people (9.8 ± 2.2 %). The difference between the indicators is statistically significant at p < 0.001 and indicates a smaller (5.4 times) number of COVID-19 cases in the cohort of health workers with a high degree of compliance with IR measures. There was no dependence of the degree of adherence of medical personnel to the principles of IC on the age, gender, medical experience and functionality of medical workers. Nosocomial cases of COVID-19 that occurred during monitoring of compliance with the requirements of the IC were characterized by polymorphism of clinical manifestations with leading respiratory syndrome, the presence of mild and moderate forms and the predominance of average medical staff among the sick. Thus, IC in the conditions of global biological threats requires constant, complete and adequate training of medical personnel in various forms, systematic professional development of all personnel on issues of hospital hygiene and infectious occupational safety, including regular annual refresher courses.

30 October 2022 in Sanitarnyj vrač (Sanitary Doctor)
Verified
Journal Article
Closed access
EZE. V. Zhukova
E. V. Zhukova
ABA. A. Burova
A. A. Burova
MMM. A. Mirskaya
M. A. Mirskaya
GNG. Y. Nikitina
G. Y. Nikitina
ASA. V. Semenenko
A. V. Semenenko
The article presents the results of the evaluation of epidemiologically significant bacterial pathogens spectrum representative of healthcare-associated infections (HAIs). Antibiotic resistance was determined in patients with a confirmed diagnosis of severe and extremely severe COVID-19 in comparison with these characteristics in patients of the intensive care unit (ICU) of surgical profile. The predominance of gram-negative bacteria producing extended-spectrum beta-lactamases (ESBLs) +: Enterobacteriaceae and nonfermenting gram-negative bacilli (NFGNB) in patients with COVID-19 and NFGNB in surgical patients was established. Gram-positive coccal microflora in the structure of nosocomial bacterial pathogens was present in a smaller number of cases. Multiple antibiotic resistance of isolated pathogens associated with HAIs was revealed in ICU patients, regardless of the profile, especially manifested in relation to beta-lactam antibiotics. It is shown that the most epidemiologically significant carbapenem-resistant pathogens received priority distribution in the ICU for patients with COVID-19, where they accounted for almost half of all microorganisms associated with HAIs. Resistance to carbapenemic antimicrobials is due to the production of extended-spectrum carbapenemase by nosomial bacterial pathogens isolated from ICU patients. The data obtained supports the strategy of adequate selection of antibacterial therapy regimens taking into account the sensitivity of the pathogen, including in patients with COVID-19. The intensive development of high-tech, invasive methods of diagnosis and treatment, combined with the widespread spread of multidrug-resistant microorganisms, determine the need for continuous improvement of the system of supervision and control of HAIs.

20 February 2023 in Sanitarnyj vrač (Sanitary Doctor)
Verified
Journal Article
Closed access
TGT. P. Gotvyanskaya
T. P. Gotvyanskaya
EME. A. Mukasheva
E. A. Mukasheva
ANA. V. Nozdracheva
A. V. Nozdracheva
NSN. B. Sipacheva
N. B. Sipacheva
ASA. V. Semenenko
A. V. Semenenko
EBElena Ivanovna Burtseva
Elena Ivanovna Burtseva
The pandemic of the new COVID-19 infection has had an impact on the epidemic process of most known infectious diseases. Given the high pandemic potential and the economic damage caused by influenza and SARS, the assessment of the prevalence of these infections in modern realities seems relevant. Aim: to assess the current manifestations of the epidemic process of SARS and influenza during the COVID-19 pandemic. Official statistics data were used to study the manifestations of epidemic processes of influenza and SARS. For serological examination, blood serum samples from conditionally healthy adults (N=270) collected in February 2022 were used. The titer of IgG antibodies to strains of influenza virus H1N1 pnm09, influenza H3N2, influenza B (Phuket), influenza B (Washington) was determined using a hemagglutination inhibition reaction. The samples were examined by enzyme immunoassay for the presence of IgG antibodies to adenovirus, respiratory syncytial (RS) virus, metapneumovirus, rhinovirus and parainfluenza viruses of types 1 and 3. Against the background of the development of the COVID-19 pandemic, an increase in the incidence of influenza has been established to a maximum value in 2021 (65.99 per 100 thousand population). The prevalence of influenza in the capital was 4.6 times higher than the average in Russia (14.96 per 100 thousand population). A significant proportion of persons immune to the influenza virus (more than 60 %) with a maximum value for the influenza B virus was identified, which is consistent with the data on the prevalence of this variant of the pathogen in the etiological interpretation of the incidence in 2021. Among the pathogens of ARVI, the maximum proportion of seropositive was detected to rhinovirus (77.8 %), which corresponds to the data on the greatest prevalence of this pathogen in the etiological structure of this group of infections. The active circulation of the influenza virus and the vaccination of the population became the basis for the formation of a high level of population immunity to the corresponding virus, which was shown by the results of the assessment of the prevalence of specific IgG antibodies.

29 January 2024 in Sanitarnyj vrač (Sanitary Doctor)
Verified
Journal Article
Closed access
EZE. V. Zhukova
E. V. Zhukova
MMM. A. Mirskaya
M. A. Mirskaya
TGT. P. Gotvyanskaya
T. P. Gotvyanskaya
ACA. N. Cairo
A. N. Cairo
ASA.V. Semenenko
A.V. Semenenko
ONO. G. Nikolaeva
O. G. Nikolaeva
A necessary condition for combating the pandemic of the new coronavirus infection (COVID-19) was the mass immunization of the population. Since any immunobiological drug can lead to the development of adverse reactions of the human body, it is necessary to characterize adverse events in the post-vaccination period. The aim of the study was to assess the frequency of registration of post-vaccination reactions in medical personnel of multidisciplinary hospitals when using vaccines against COVID-19, approved for use in the Russian Federation. An anonymous questionnaire was developed, using which 2,989 medical workers from Moscow, Moscow, Tula, Vladimir, and Kaluga regions were interviewed between December 2021 and February 2022. It was found that the overwhelming majority of medical professionals rated the tolerability of vaccines against COVID-19 as good and satisfactory. No serious adverse effects of immunization have been identified. There were short-term post-vaccination reactions, manifested in an increase in body temperature, headache, general weakness, myalgia and arthralgia, as well as fever, pain, swelling, itching at the injection site. In more than 82 % of cases, the above reactions developed within the first three days after vaccination. When comparing the results of a retrospective one-stage cross-sectional online study (n = 6032) with the data we obtained, a comparable frequency of post-vaccination reactions was revealed. Thus, the study established good tolerability and low frequency of post-vaccination reactions during immunization against COVID-19.

20 July 2023 in Sanitarnyj vrač (Sanitary Doctor)
Verified
Journal Article
Closed access
GNG. Y. Nikitina
G. Y. Nikitina
OOO. A. Orlova
O. A. Orlova
ASA. V. Semenenko
A. V. Semenenko
ESE. O. Shavlova
E. O. Shavlova
TGT. P. Gotvyanskaya
T. P. Gotvyanskaya
Medical personnel belong to the occupational risk group of hepatitis B virus (HBV) infection due to the increase of parenteral interventions and procedures using sophisticated equipment, constant contact with biological fluids of patients, the widespread use of antibiotics and cytostatics that have an immunosuppressive effect, etc. Insufficient objectivity in assessing the quality of hepatitis B (HBV) immunoprophylaxis only according to documentation may be associated with a violation of immunization regimens, the presence of chronic pathology in vaccinated, age-related immunodeficiency. Despite the effectiveness of HCV vaccination, the protective activity of specific humoral immunity (antibodies to HBsAg — anti-HBs) among vaccinated medical workers has not been sufficiently studied. The results of studying the intensity and duration of the immune response in 2075 employees of two large multidisciplinary hospitals vaccinated against HBV (average age 46.3 ± 10.1 years) are presented. A high level of vaccination coverage of medical personnel in hospitals No. 1 and No. 2 was established, amounting to 96.6 % and 97.2 %, and the level of collective immunity was equal to 1645.5±72.5 IU/l and 886±123.7 IU/l, respectively. The absence of cases of HBV in vaccinated individuals during immunoprophylaxis according to the standard scheme was noted. It seems advisable to use an individual approach to the tactics of revaccination when reducing the content of anti-HBs in the blood to low concentrations (10–100 IU / l), preventing them from falling below the protective level.